Tag results:
AKT
Pulmonary Cell News
MicroRNA-631 Deriving from Bone Marrow Mesenchymal Stem Cell Exosomes Facilitates the Malignant Behavior of Non-small Cell Lung Cancer via Modulating the E2F Family of...
[Bioengineered] Researchers explored the potential mechanism of exosome-derived miR-631 targeting and regulating E2F family of transcription factor 2 to repress the malignant behavior of NSCLC cells.
Muscle Cell News
Adiponectin Receptor Agonist Ameliorates Cardiac Lipotoxicity via Enhancing Ceramide Metabolism in Type 2 Diabetic Mice
[Cell Death & Disease] Phenotypic and metabolic profiles with associated cellular signaling pathways involved in lipid metabolism were investigated in the mice heart and human cardiomyocytes to establish treatment effect of adiponectin's agonists.
Cancer Stem Cell News
Low-Temperature Plasma-Activated Medium Inhibited Proliferation and Progression of Lung Cancer by Targeting the PI3K/Akt and MAPK Pathways
[Oxidative Medicine and Cellular Longevity] Scientists explored the effect of the plasma-activated medium on lung cancer cells in vitro and in vivo by using a 3D cell culture model.
Pancreatic Cell News
IGF-1 Ameliorates Streptozotocin-Induced Pancreatic β Cell Dysfunction and Apoptosis via Activating IRS1/PI3K/Akt/FOXO1 Pathway
[Inflammation Research] Scientists demonstrated the protective role of Insulin-like growth factor 1 (IGF-1) against pancreatic β cell dysfunction and to probe into the underlying mechanisms.
Endothelial Cell News
Glioma-Derived Exosomes Hijack the Blood–Brain Barrier to Facilitate Nanocapsule Delivery via LCN2
[Journal of Controlled Release] Scientists found that exosomes from primary brain tumors could upregulate the expression of lipocalin-2 in bEnd.3 brain microvascular endothelial cells
Hepatic Cell News
Cellular Heterogeneity and Transcriptomic Profiles during Intrahepatic Cholangiocarcinoma Initiation and Progression
[Hepatology] Researchers performed single-cell RNA-sequencing using AKT/NICD-induced mouse intrahepatic cholangiocarcinoma tissues at early, middle, and late stages.